Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.018 |
Chemical and physical data | |
Formula | C10H15NO2 |
Molar mass | 181.235 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Hexapropymate is a hypnotic/sedative. It has effects similar to those of barbiturates and was used in the 1970s-1980s in the treatment of insomnia before being replaced with newer drugs with improved safety profiles.[1]
References
- ↑ Gustafsson LL, Berg A, Magnusson A, Malmlund HO, Sandell BM, Stig R (1989). "Hexapropymate self-poisoning causes severe and long-lasting clinical symptoms". Medical Toxicology and Adverse Drug Experience. 4 (4): 295–301. doi:10.1007/bf03259914. PMID 2770531. S2CID 24560026.
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids | |
Imidazoles | |
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines | |
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.